EUCTR2009-011560-11-IT进行中（未招募）不适用
Effects of three oral dosage of S 44121 on cardiac arrhythmia during exercise testing in patients with catecholaminergic polymorphic ventricular tachycardia type 1. A 3-days, single-blind, international multicentre study. - ND
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Male or female, age superior or equal to 18 years - Established diagnosis of CPVT type1 - Treatment with beta-blocker - Qualifying ETs meeting a predefined degree of severity and stability of the disease.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Resting ECG with an abnormality that could preclude a proper interpretation of the ECG obtained during the ETs. - Chronic heart failure. - Structural congenital heart disease.
研究者
相似试验
进行中（未招募）
1 期
Effects of three oral dosages of S 44121 on cardiac arrhythmia during exercise testing in patients with catecholaminergic polymorphic ventricular tachycardia type 1. A 3-day, single-blind, international multicentre study.Catecholaminergic polymorphic ventricular tachycardia (CPVT) type 1MedDRA version: 12.0Level: LLTClassification code 10036095Term: Polymorphic ventricular tachycardiaEUCTR2009-011560-11-FRInstitut de Recherches Internationales Servier16
进行中（未招募）
不适用
Effects of three oral dosages of S 44121 on cardiac arrhythmia during exercise testing in patients with catecholaminergic polymorphic ventricular tachycardia type 1. A 3-day, single-blind, international multicentre study.Catecholaminergic polymorphic ventricular tachycardia (CPVT) type 1MedDRA version: 12.0Level: LLTClassification code 10036095Term: Polymorphic ventricular tachycardiaEUCTR2009-011560-11-FIInstitut de Recherches Internationales Servier16
进行中（未招募）
不适用
Evaluation of the effects of 4 oral dosages of S 44121 in patients with chronic heart failure and left ventricular dysfunction not treated with a beta-blocker.Chronic heart failure and left ventricular dysfunctionMedDRA version: 14.1Level: PTClassification code 10007558Term: Cardiac failure chronicSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 14.1Level: PTClassification code 10049694Term: Left ventricular dysfunctionSystem Organ Class: 10007541 - Cardiac disordersEUCTR2009-011559-38-DEInstitut de Recherches Internationales Servier125
进行中（未招募）
不适用
Evaluation of the effects of 4 oral dosages of S 44121 versus placebo on cardiac function and NT-proBNP in patients with chronic heart failure and left ventricular dysfunction. A 12-week, randomized, double-blind, parallel-group, placebo controlled, international multicentre study.EUCTR2009-011558-16-DEInstitut de Recherches Internationales Servier150
进行中（未招募）
不适用
Evaluation of the effects of 4 oral dosages of S 44121 in patients with chronic heart failure and left ventricular dysfunction not treated with a beta-blocker.Chronic heart failure and left ventricular dysfunctionMedDRA version: 14.0Level: PTClassification code 10049694Term: Left ventricular dysfunctionSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 14.0Level: PTClassification code 10007558Term: Cardiac failure chronicSystem Organ Class: 10007541 - Cardiac disordersEUCTR2009-011559-38-LVInstitut de Recherches Internationales Servier125